Youngjun Shin

Q: What is Youngjun Shin email address?

Email Youngjun Shin at youngjunshin@msn.com and youngjun@innocurethera.com. This email is the most updated Youngjun Shin's email found in 2026.

Q: How to contact Youngjun Shin?

To contact Youngjun Shin send an email to youngjunshin@msn.com or youngjun@innocurethera.com. (updated on September 02, 2024)

Chief Scientific Officer at Innocure Therapeutics | San Diego, California, United States

About Youngjun Shin

As the Chief Scientific Officer at Innocure Therapeutics, Youngjun Shin plays a pivotal role in advancing the company’s mission to develop innovative small molecule therapies targeting oncology. With a strong foundation in organic chemistry and a keen focus on protein degradation mechanisms, Youngjun leads key projects centered around PROTAC (Proteolysis Targeting Chimeras) technology, which harnesses the body’s natural protein degradation pathways to selectively eliminate cancer-promoting proteins. His expertise in organometallic synthesis and multi-step organic synthesis enables the design and development of novel therapeutic candidates, while his proficiency in DMPK (Drug Metabolism and Pharmacokinetics) ensures that these compounds are not only effective but also safe and viable for clinical use.

Youngjun's management style is characterized by a hands-on approach that fosters collaboration among cross-functional teams, including the DMPK group and external partners such as Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). His excellent communication skills facilitate seamless interactions, ensuring that biological data is effectively managed and utilized to inform project decisions. Currently, he is spearheading initiatives that leverage DNA-encoded libraries and explore the therapeutic potential of GPCRs (G-Protein Coupled Receptors) in cancer treatment, positioning Innocure Therapeutics at the forefront of biotechnology innovation.

With a robust background in protein chemistry, purification techniques, and medicinal chemistry, Youngjun is not only a leader in the pharmaceutical industry but also a visionary committed to transforming the landscape of cancer therapeutics. His strategic direction and scientific acumen are instrumental in driving the company’s research agenda and translating complex scientific concepts into actionable therapeutic solutions.

Youngjun Shin Work